CClinicalTrials.gg
Sign In
CompletedNCT02649049Updated Sep 22, 2016

Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

An observational study in Dietary Intake and NAFLD, sponsored by National Nutrition and Food Technology Institute. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-22.

Sponsored by National Nutrition and Food Technology Institute · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
1,200
Ages
18 Years and older
Sex
All
01

Study summary

Patients with NAFLD and matched controls will be asked about their demographic status, and their previous year dietary intakes using a validated FFQ.

02

Conditions studied

  • Dietary Intake
  • NAFLD
03

In context

Liver Diseases

2,080 studies on the registry are indexed under Liver Diseases; 389 are open to participants now.

This study's enrollment of 1,200 is above the median of 167 across 681 observational studies indexed under Liver Diseases.

Browse Liver Diseases studies →

Lead sponsor

National Nutrition and Food Technology Institute is the lead sponsor of 62 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

patients with NAFLD diagnosed using Fibroscan without any other chronic disorders.

Inclusion criteria

  • age more than 18
  • NAFLD was diagnosed by Fibroscan and other hepatic disorders ruled out

Exclusion criteria

Exclusion Criteria:

  • not completing more than 10% of the questionnaire
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
1,200 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with NAFLD

    Patients with NAFLD are the cases.

    Other: there is no intervention

  • control group

    Healthy people without NAFLD are controls.

    Other: there is no intervention

Interventions

  • Otherthere is no intervention
06

What researchers measure

Primary outcomes

  1. nonalcoholic fatty liver disease diagnosed by Fibroscan

    patients with confirmed diagnosis will be asked about their dietary intakes

    Time frame: 6 months

07

Study locations

1 site
  • NNFTRI clinic
    Tehran, 19435, Iran, Islamic Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02649049
Lead sponsor
National Nutrition and Food Technology Institute
Responsible party
Dr Azita Hekmatdoost (Associate Prof, National Nutrition and Food Technology Institute) — Principal investigator
First posted
Jan 7, 2016
Start date
Jan 2015
Primary completion
Feb 2016
Completion
Mar 2016
Last update
Sep 22, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Liver Diseases→

Other studies from this sponsor

National Nutrition and Food Technology Institute

Start the discussion